How to choose liver cancer systemic treatment plan?JCO speaks with research data!
Author:Cancer Channel of the Medical Time:2022.06.20
*For medical professionals for reading reference
Think useful?Quickly forward to the circle of friends!
Hepatocytate (HCC) has now been listed as the third largest cause of death in the world, and its incidence has continued to rise.Although the management of hepatitis B and hepatitis C has improved, people are increasingly worried that the development of fatty liver and cirrhosis has brought cancer development, which will increase global cases.
Before 2008, no systemic therapy could improve the overall survival rate (OS) of patients with advanced liver cancer.
Scan the QR code below, read the latest medication information
- END -
Two or three people participate, almost 100,000+, the secret of the explosion is actually it
Original: Chen YingSince the beginning of this year, Tianjin, Shanghai, Changchun,...
How to control the secret and closely connected secret?Shanghai is clear!Social positive +1, 16 supe
Today (June 13) at 17:00, the Shanghai Municipal Government News Office organized a press conference of the 211th publication work of the new crown pneumonia epidemic in Shanghai. Zhao Dandan, deputy